Structure Therapeutics Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Structure Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2022 to 2024.
  • Structure Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$36.5M, a 48.9% decline year-over-year.
  • Structure Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$123M, a 36.7% decline year-over-year.
  • Structure Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$123M, a 36.7% decline from 2023.
  • Structure Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$89.6M, a 74.6% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$123M -$32.9M -36.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$89.6M -$38.3M -74.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$51.3M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.